Personalized medicine for prevention: can risk stratified screening decrease colorectal cancer mortality at an acceptable cost?

MLA

Subramanian, Sujha, et al. “Personalized Medicine for Prevention: Can Risk Stratified Screening Decrease Colorectal Cancer Mortality at an Acceptable Cost?” Cancer Causes & Control, vol. 28, no. 4, Apr. 2017, pp. 299–308. EBSCOhost, https://doi.org/10.1007/s10552-017-0864-4.

APA

Subramanian, S., Bobashev, G., Morris, R., Hoover, S., & Morris, R. J. (2017). Personalized medicine for prevention: can risk stratified screening decrease colorectal cancer mortality at an acceptable cost? Cancer Causes & Control, 28(4), 299–308. https://doi.org/10.1007/s10552-017-0864-4

Chicago

Subramanian, Sujha, Georgiy Bobashev, Robert Morris, Sonja Hoover, and Robert J Morris. 2017. “Personalized Medicine for Prevention: Can Risk Stratified Screening Decrease Colorectal Cancer Mortality at an Acceptable Cost?” Cancer Causes & Control 28 (4): 299–308. doi:10.1007/s10552-017-0864-4.